Result: it was identified that the cautery that was provided with the gelweave graft has a shorter shelf life indicated on its label as that of the graft.Four years versus 5 years.In order to address the labeling deficiency, vascutek is proposing a field safety corrective action to remove the cautery from this product packaging and for this action to occur as a correction in the field.On the basis of the health hazard determination and in accordance with current fda guidelines on recalls, corrections and removals (devices), part 21 cfr806 "corrections and removals" this would be classed as a class ii recall, under the term of a correction/removal.A full report in accordance with fda part 806 (c) will be prepared and sent to the fda by (b)(4).
|